Digoxin-like immunoreacting activity in the serum of patients on regular hemodialysis. 1986

J Madrenas, and S Codina, and J Monné, and M V García-Lucena, and J A Rodríguez, and E Ferrer, and L Piera

UI MeSH Term Description Entries
D007676 Kidney Failure, Chronic The end-stage of CHRONIC RENAL INSUFFICIENCY. It is characterized by the severe irreversible kidney damage (as measured by the level of PROTEINURIA) and the reduction in GLOMERULAR FILTRATION RATE to less than 15 ml per min (Kidney Foundation: Kidney Disease Outcome Quality Initiative, 2002). These patients generally require HEMODIALYSIS or KIDNEY TRANSPLANTATION. ESRD,End-Stage Renal Disease,Renal Disease, End-Stage,Renal Failure, Chronic,Renal Failure, End-Stage,Chronic Kidney Failure,End-Stage Kidney Disease,Chronic Renal Failure,Disease, End-Stage Kidney,Disease, End-Stage Renal,End Stage Kidney Disease,End Stage Renal Disease,End-Stage Renal Failure,Kidney Disease, End-Stage,Renal Disease, End Stage,Renal Failure, End Stage
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D011863 Radioimmunoassay Classic quantitative assay for detection of antigen-antibody reactions using a radioactively labeled substance (radioligand) either directly or indirectly to measure the binding of the unlabeled substance to a specific antibody or other receptor system. Non-immunogenic substances (e.g., haptens) can be measured if coupled to larger carrier proteins (e.g., bovine gamma-globulin or human serum albumin) capable of inducing antibody formation. Radioimmunoassays
D004077 Digoxin A cardiotonic glycoside obtained mainly from Digitalis lanata; it consists of three sugars and the aglycone DIGOXIGENIN. Digoxin has positive inotropic and negative chronotropic activity. It is used to control ventricular rate in ATRIAL FIBRILLATION and in the management of congestive heart failure with atrial fibrillation. Its use in congestive heart failure and sinus rhythm is less certain. The margin between toxic and therapeutic doses is small. (From Martindale, The Extra Pharmacopoeia, 30th ed, p666) Digacin,Digitek,Digoregen,Digoxina Boehringer,Digoxine Nativelle,Dilanacin,Hemigoxine Nativelle,Lanacordin,Lanicor,Lanoxicaps,Lanoxin,Lanoxin-PG,Lenoxin,Mapluxin,Boehringer, Digoxina,Lanoxin PG,Nativelle, Digoxine,Nativelle, Hemigoxine
D005260 Female Females
D006435 Renal Dialysis Therapy for the insufficient cleansing of the BLOOD by the kidneys based on dialysis and including hemodialysis, PERITONEAL DIALYSIS, and HEMODIAFILTRATION. Dialysis, Extracorporeal,Dialysis, Renal,Extracorporeal Dialysis,Hemodialysis,Dialyses, Extracorporeal,Dialyses, Renal,Extracorporeal Dialyses,Hemodialyses,Renal Dialyses
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000293 Adolescent A person 13 to 18 years of age. Adolescence,Youth,Adolescents,Adolescents, Female,Adolescents, Male,Teenagers,Teens,Adolescent, Female,Adolescent, Male,Female Adolescent,Female Adolescents,Male Adolescent,Male Adolescents,Teen,Teenager,Youths
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults

Related Publications

J Madrenas, and S Codina, and J Monné, and M V García-Lucena, and J A Rodríguez, and E Ferrer, and L Piera
January 1985, Nephron,
J Madrenas, and S Codina, and J Monné, and M V García-Lucena, and J A Rodríguez, and E Ferrer, and L Piera
April 1994, Nihon Jinzo Gakkai shi,
J Madrenas, and S Codina, and J Monné, and M V García-Lucena, and J A Rodríguez, and E Ferrer, and L Piera
January 1989, Cardiovascular drugs and therapy,
J Madrenas, and S Codina, and J Monné, and M V García-Lucena, and J A Rodríguez, and E Ferrer, and L Piera
January 1985, Regulatory peptides. Supplement,
J Madrenas, and S Codina, and J Monné, and M V García-Lucena, and J A Rodríguez, and E Ferrer, and L Piera
January 1985, Klinische Wochenschrift,
J Madrenas, and S Codina, and J Monné, and M V García-Lucena, and J A Rodríguez, and E Ferrer, and L Piera
January 1991, Life sciences,
J Madrenas, and S Codina, and J Monné, and M V García-Lucena, and J A Rodríguez, and E Ferrer, and L Piera
September 2006, Saudi journal of kidney diseases and transplantation : an official publication of the Saudi Center for Organ Transplantation, Saudi Arabia,
J Madrenas, and S Codina, and J Monné, and M V García-Lucena, and J A Rodríguez, and E Ferrer, and L Piera
February 2009, Clinical nephrology,
J Madrenas, and S Codina, and J Monné, and M V García-Lucena, and J A Rodríguez, and E Ferrer, and L Piera
June 1992, Polskie Archiwum Medycyny Wewnetrznej,
J Madrenas, and S Codina, and J Monné, and M V García-Lucena, and J A Rodríguez, and E Ferrer, and L Piera
January 1987, American journal of nephrology,
Copied contents to your clipboard!